Next Article in Journal
Two New Spiro-Heterocyclic γ-Lactams from A Marine-Derived Aspergillus fumigatus Strain CUGBMF170049
Next Article in Special Issue
Oyster-Derived Zinc-Binding Peptide Modified by Plastein Reaction via Zinc Chelation Promotes the Intestinal Absorption of Zinc
Previous Article in Journal
Flaccidoxide-13-Acetate-Induced Apoptosis in Human Bladder Cancer Cells is through Activation of p38/JNK, Mitochondrial Dysfunction, and Endoplasmic Reticulum Stress Regulated Pathway
Previous Article in Special Issue
Protective Effect of Pyropia yezoensis Peptide on Dexamethasone-Induced Myotube Atrophy in C2C12 Myotubes
Article

Antihypertensive Effect in Vivo of QAGLSPVR and Its Transepithelial Transport Through the Caco-2 Cell Monolayer

1
Yunnan Institute of Food Safety, Kunming University of Science and Technology, No. 727 South Jingming Road, Kunming 650500, China
2
Shandong Provincial Key Laboratory of Biochemical Engineering, College of Marine Science and Biological Engineering, Qingdao University of Science and Technology, Qingdao 266042, China
3
Food Science and Technology, Ocean University of China, No 5, Yushan Road, Qingdao 266005, China
*
Author to whom correspondence should be addressed.
Mar. Drugs 2019, 17(5), 288; https://doi.org/10.3390/md17050288
Received: 23 March 2019 / Revised: 17 April 2019 / Accepted: 25 April 2019 / Published: 13 May 2019
The peptide QAGLSPVR, which features high angiotensin-I-converting enzyme (ACE) inhibitory activity, was identified in our previous study. In this study, the in vivo antihypertensive effect of QAGLSPVR was evaluated. Results showed that QAGLSPVR exerts a clear antihypertensive effect on spontaneously hypertensive rats (SHRs), and the systolic and diastolic blood pressures of the rats remarkably decreased by 41.86 and 40.40 mm Hg, respectively, 3 h after peptide administration. The serum ACE activities of SHRs were determined at different times, and QAGLSPVR was found to decrease ACE activities in serum; specifically, minimal ACE activity was found 3 h after administration. QAGLSPVR could be completely absorbed by the Caco-2 cell monolayer, and its transport percentage was 3.5% after 2 h. The transport route results of QAGLSPVR showed that Gly-Sar and wortmannin exert minimal effects on the transport percentage of the peptide (p> 0.05), thus indicating that QAGLSPVR transport through the Caco-2 cell monolayer is not mediated by peptide transporter 1 or transcytosis. By contrast, cytochalasin D significantly increased QAGLSPVR transport (p< 0.05); thus, QAGLSPVR may be transported through the Caco-2 cell monolayer via the paracellular pathway. View Full-Text
Keywords: QAGLSPVR; antihypertensive effect; Caco-2 cell monolayer; transport routes QAGLSPVR; antihypertensive effect; Caco-2 cell monolayer; transport routes
Show Figures

Figure 1

MDPI and ACS Style

Sun, L.; Wu, B.; Yan, M.; Hou, H.; Zhuang, Y. Antihypertensive Effect in Vivo of QAGLSPVR and Its Transepithelial Transport Through the Caco-2 Cell Monolayer. Mar. Drugs 2019, 17, 288. https://doi.org/10.3390/md17050288

AMA Style

Sun L, Wu B, Yan M, Hou H, Zhuang Y. Antihypertensive Effect in Vivo of QAGLSPVR and Its Transepithelial Transport Through the Caco-2 Cell Monolayer. Marine Drugs. 2019; 17(5):288. https://doi.org/10.3390/md17050288

Chicago/Turabian Style

Sun, Liping, Beiyi Wu, Mingyan Yan, Hu Hou, and Yongliang Zhuang. 2019. "Antihypertensive Effect in Vivo of QAGLSPVR and Its Transepithelial Transport Through the Caco-2 Cell Monolayer" Marine Drugs 17, no. 5: 288. https://doi.org/10.3390/md17050288

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop